SPONSOR
Regina Elena Cancer Institute
Total Trials
5
Recruiting
5
Phases
N/A
Conditions studied: GliomaHead and Neck TumorsCervical Cancer Stage IB2Cervical Cancer Stage IIaCervical Cancer Stage IBCervical Cancer Stage IIIAProstatic NeoplasmsNSCLC
Regina Elena Cancer Institute is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Glioma, Head and Neck Tumors, Cervical Cancer Stage IB2, Cervical Cancer Stage IIa.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Regina Elena Cancer Institute
How many clinical trials has Regina Elena Cancer Institute sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Regina Elena Cancer Institute, of which 5 are actively recruiting participants. These trials cover conditions including Glioma, Head and Neck Tumors, Cervical Cancer Stage IB2. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Regina Elena Cancer Institute research focus on?
Regina Elena Cancer Institute clinical trials span Glioma, Head and Neck Tumors, Cervical Cancer Stage IB2, Cervical Cancer Stage IIa, Cervical Cancer Stage IB, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Regina Elena Cancer Institute clinical trial?
To participate in a Regina Elena Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Regina Elena Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Regina Elena Cancer Institute
NCT06883214
Recruiting
Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application
Glioma
NCT06791941
Recruiting
Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer
Head and Neck Tumors
NCT07248878
Recruiting
Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy
Cervical Cancer Stage IB2
NCT06894628
Recruiting
Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation
Prostatic Neoplasms
NCT06807307
Recruiting
Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential
NSCLC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology